Stories of Success
On April 11, 2013, the pharmaceutical company Sanofi launched the large-scale production of a partially synthetic version of artemisinin, a chemical critical to making today’s frontline anti-malaria drug based on Dr. Jay Keasling’s discovery at UC Berkeley.
To read more about this story, visit the UC Berkeley News Center.
More Stories
News & Events
Read more +
03 March 2014 By uamin in eventsMar 29, 2014: Bay Area Microbial Pathogenesis Symposium XVIII
Read more +
02 March 2014 By uamin in eventsMar 21, 2014: Call for Abstracts – 2014 Bay Area World Malaria Day Symposium
Opportunities
Read more +
03 March 2014 By uamin in funding opportunitiesIntegrated Preclinical/Clinical AIDS Vaccine Development Program (IPCAVD) (U19)
Read more +
19 February 2014 By uamin in funding opportunitiesMar 31, 2014: UC Global Health Day Video Contest
Read more +
18 February 2014 By uamin in funding opportunitiesMar 21, 2014: UC Berkeley MHIRT Faculty/Mentor Travel Awards
Diagnostics by Design: a hack day for global health – Team Respire, 3rd Place Prize
2014 Diagnostics by Design: A Hack Day for Global Health , Global Heath Diagnostics (GHDx) , UC Berkeley , VideosDiagnostics by Design: a hack day for global health – Team Visionaries, 2nd Place Prize
2014 Diagnostics by Design: A Hack Day for Global Health , Global Heath Diagnostics (GHDx) , UC Berkeley , VideosDiagnostics by Design: a hack day for global health – Team M@RS, 1st Place Prize
2014 Diagnostics by Design: A Hack Day for Global Health , Global Heath Diagnostics (GHDx) , UC Berkeley , VideosDiagnostics by Design: A Hack Day for Global Health, Time-Lapse Video
2014 Diagnostics by Design: A Hack Day for Global Health , Global Heath Diagnostics (GHDx) , UC Berkeley , Videos
Henry Wheeler Center for Emerging and Neglected Diseases (CEND)
The Henry Wheeler Center for Emerging & Neglected Diseases (CEND) was established as a multi-disciplinary research unit in 2008, with the support of a generous donation by Henry H. “Sam” Wheeler, Jr. The mission of CEND is to help the University of California, Berkeley make innovative and substantial contributions to the global response to emerging and neglected infectious diseases. We at CEND believe that by educating potential innovators, connecting researchers from diverse disciplines, and investing in research, we can help the best and brightest minds at UC Berkeley access the resources they need to make meaningful and innovative contributions to our scientific understanding and ability to combat emerging and neglected diseases.